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   Determination of the lipolytic activity in various organs of rats were 
done by means of organ homogenate in vitro, the significance of the 
lipolytic activity was more characterized by the inhibition study of the 
Lipoprotein Lipase (LPL). The activity of the lung tissue was high followed 
by the cardiac muscle or adipose tissue. After force feeding fat meal or after 
heparin administration in vitro, the significant elevation was observed. 
And also after carbon tetrachloride poisoning or aseptic pneumonia induced 
by silver nitrate solution injection, the lipolytic activity in the lung 
increased with the endogeneous lipid transportation from the depot fat to 
the liver tissue. The histological character of the lung tissue is rich in 
arterioles and capillaries and also rich in mast cells and the lung has a 
anatomical speciality ; the first organ to be approached by exogeneous 
lipid. These findings suggest that the lung is one of the organs which 
produce LPL and may display some role in the exogeneous and endogeneous 
lipid transportation.
   In 1943 HAHN" discovered the rapid clearing of alimentary lipemia 
in dogs by the injection of heparin, and in 1950 Anderson and Fawcett" 
demonstrated that plasma obtained after heparin injection contained a 
factor which cleared lipemia in vitro. 
Many studies""''"'' on clearing factor were achieved in the past 
20 years and the clearing factor was proved to be anew enzyme, which 
was neither esterase, pancreatic lipase nor tributylinase. Although the 
clearing factor has not yet been obtained in pure form, its action has 
been definite to catalyse the hydrolysis of triglyceride moiety of chylo-
microns and low density lipoproteins, because free fatty acid was 
liberated in plasma during the clearing of the postalimental lipemic 
plasma. 
   On the other hand, studies on the Lipoprotein Lipase (LPL) activity 
in the tissue"' "°'"were at first undertaken in adipose tissue concern-
ing a nutritional state or a neurohumoral disturbances, and in cardiac
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muscle""' .-i' which takes up free fatty acid as the energy source. 
   Although there are many difficulties in method to determine LPL 
activity of the tissue, LPL in plasma and in tissue would be identical 
by the theoretical point of view"). 
   It is generally believed that LPL plays a important role in transfer 
of fat from the circulating blood into a peripheral tissues"""). 
It has been supposed by some investigators that the disturbance of 
the lipid metabolism might happen in pulmonary diseases""", because 
lipemia has been often observed clinically in pneumonia and lung 
cancer, and fatty liver has been recognized in autopsies of pulmonary 
tuberculosis'". 
   Also, the lung is anatomically positioned as the first organ to be 
approached from the exogeneous fat. 
   These facts would be sufficient to suggest the close relationship 
between the lung and neutral lipid transportation in lipid metabolism. 
   In this study, two experiments on LPL activity were undertaken 
for the resolution of these problems. The first was the improvement 
of the LPL assay-method because the leading method has been insuffi-
cient in sensitivity to detect it in tissues and the second was to eval-
uate the LPL activity in lung comparing with adipose tissue, liver, 
heart and kidney which were thought to be the most active organ in 
lipid metabolism, especially in lipoprotein and non-esterified fatty acid 
(NEFA) metabolism. 
   I. Experiment for Confirmation of LPL Activity Assay in Organ. 
   Materials and Method 
   Preparation of materials ; Wister-strain male albino rats from 180 to 
250 g body weight, were used. The rats were fed with regular stock 
diet and water ad libitum until the biginning of the experiment. The 
experimental animals were fasted overnight before the experiment, and 
were anesthetized with 5 mg/100g body weight sodium pentobarbital 
and then they were killed by decapitation. Each organ was immediately 
removed, and washed with physiological saline solution. Each tissue, 
weighing exactly 500 mg was placed into the glass homogenizer with 2 
ml of 0.9% physiological saline solution. After homogenizing them in 
the cold, the homogenate was centrifuged for 10 minutes at 3000 rpm 
in 0°C, the supernatant layer was separated, and each ml of them was 
supplied to the measurement of lipolytic activity (LA). 
   Assay of lipolytic activity ; The substrate consisted of 0.1 vol. of 20 
  Fatgen (sesame oil emulsion), 1 vol. of dogs oxalated plasma (pooled 
from several dogs, heated at 56°C for 10 minutes, immediatly cooled, 
centrifuged to remove the fibrin and stored at -20°C), 1 vol. of 5% 
bovine albumin and 2 vol. of tris-hydroxymethyl aminomethane buffer 
(pH 7.7). The substrate was preincubated at 37°C for 30 minutes just 
before use,
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   Immediately after mixing 1 ml of the sample into 2 ml of substrate, 
1 ml of the mixture was pipetted into Dole's'") extraction mixture and 
remaining mixture was continued to incubated at 37°C for 60 minutes. 
Thereafter 1 ml of the mixture was also pipetted into the Dole's mixture. 
   NEFA was measured by Dole's method"'). Namely, 1 ml of sample 
are added into a glass-stoppered test tube with 5 ml extraction mixture 
and shaken for 10 minutes. And then 3 ml heptane and 2 ml water 
are added and the mixture are shaken again for 5 minutes. To a final 
tube containing 1 ml Dole's titration mixture is transferred 3 ml of the 
heptane layer and it is then titrated with 0.018 N sodium hydroxide 
while being agitated with a stream of nitrogen. The heptane layers 
from appropriate titration blanks and palmitic acid standards are 
similarly titrated, in every experiment. The differences of NEFA 
concentration in the mixture before and after the incubation were 
calcurated. The protein concentration in the homogenate was determined 
by Biuret's method, and then the unit of activity was expressed m, e 
moles of linoleic acid formed per hour per mg protein. 
Results 
   The effect of pH in the reactions medium were observed. The 
lipolytic activity was measured by using the lung homogenate in the 
following varing pH of the substrate, pH 7.0, 7.4, 7.7, 8.0, 8.5 and 
8.9. The results were shown in Fig. 1.
Fig. 1. Effects of pH on the Lipolytic Activity
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   These observations suggest that pH 7.7 is optimum for the measu-
rement of the lipolytic activity. 
   As a fatty acid acceptor in the reaction mixture, the bovine 
albumin solution were used, and the influence of albumin concent-
ration was observed. 
   The lipolytic activities were measured by using the lung homogenate 
in the following varing the concentration, 2.5%, 5.0%, , 10.0%, 20.0 
and 0.9% physiological saline solution, instead of albumin solution. 
The results were shown in Fig. 2.
Fig. 2
   It seems that 5 % albumin solution in the reaction mixture is quite 
enough as the fatty acid acceptor. 
   When dog plasma was used as a part of the substrate, an influence 
of the inhibitor must be taken into consideration. B. HOOD"', G. 
ANGERVALL22'23' , F. C. MONKHOUSE and P. G. MACKNESON24' had studied 
the inhibitor in plasma which was removed by heating the plasma in 
56°C. This problem was examined. Postheparin plasma was used as a 
lipolytic enzyme source. (The dog blood was collected at 10 minutes 
after an intravenous injection of 100 units of heparin per 100g of body 
weight, and plasma was obtained by centrifuging the blood for 10 
minutes at 3000 rpm in cold.)
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             Fig. 3. Effects of heating at 56°C for varing lengths of 
                         time on pools of dog plasma.
Fig. 4. Effects of Incubation Time on the Lipolytic Activity.
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   Heating 10 minutes appears optimum, therefore, the dog plasma
used for the substrate was heated in a water bath at 56°C for 10 
minutes, cooled immediately, centrifuged, and stored at -20°C. 
   Incubation time: Using lung homogenate as the lipolytic enzyme 
source, the lipolytic activity was measured in various incubation time. 
   As the results shown in Fig. 4, approximately quadratic curve 
was obtained. This curve shows that the amount of the lipolytic activity 
in the first 60 minutes was larger than that in the next 60 minutes. 
Discussion 
   The pH in the medium, the concentration of albumin solution added 
to the substrate as NEFA acceptor, and the incubation time were 
examined and the optimal conditions in this enzymatic reaction system 
were obtained. High level of the lipolytic activities were detected in 
pH 7.7 which is in close agreement with the results of G. Murakami 
and others. The object for the NEFA acceptor was attained completely 
by adding 5 % albumin solution to the medium. It is agreeable to the 
results of D. S. Robinson and others that the increase rate of NEFA 
was linear in the first 60 minutes incubation. 
   When G. Angervall, B. Hood"~")~ and others studied on the 
lipemia clearing enzyme in plasma of the atherosclerotic patients and 
hypercholesterolemic patients, they discovered an inhibitory effect in 
the post-heparin plasma on the clearing phenomenon. And thereafter 
the details of this inhibitory factor was studied by several investigators. 
F. C. Monkhouse24' and others examined exactly the inhibitor which 
inhibits the release of NEFA from the chylomicrons in plasma, and 
they pointed out the variation of inhibitory effects in species and 
individuals. 
   In this experiment of LPL assay in tissues, the dog oxalated plasma 
was used in the substrate, and the inactivation of inhibitors in the 
plasma were done by means of heating them at 56°C in water bath 
according to the techinique of Monkhouse. And the affection of this 
treatment on the lipolytic activity was detected. 
   The results above mentioned, emphasized that it is better to use 
the inhibitor free plasma when dog plasma is used as substrate, because 
the influence of the inhibitor is so great as approximately one half time 
of it leading. 
   II. Experiment for Evaluation of LPL Activity in various Organs 
   especially in Lung. 
Treatment of Animals. 
   The animals, which were supplied in this experiment, were in 
similar condition to the previous experiment and divided into three 
groups. 
   1) Six rats were injected 0.25m1/100g body weight of carbon tetra-
chloride into the gluteus muscle, and other five rats were fed 0.5
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ml/100g body weight of a mixture consisting 1 vol. of carbon tetrachloride 
and 1 vol. of -olive oil. Force-feeding was done through a stomach tube 
under sodium pentobarbital anaesthesia (intraperitoneal injection of 5 
mg/100g body weight). Sixteen hours after carbon tetrachloride admini-
stration, these rats were killed by decapitation. 
   2) Eight.rats were force-fed 0.5 ml/100g body weight of olive oil. 
Four rats were killed after 3 hours and other four rats after 5 hours 
by decapitation. 
   3) Five rats were administered with 0.05 ml of 1%' silver nitrate 
solution by intratracheal injection and killed after 24 hours. At this 
time, the findings of aseptic pneumonia were seen macro- and microsco-
pically. 
   Immediately after autopsy of these 3 type treated rats, lung, 
adipose tissue, liver, kidney and heart were removed for the determin-
ation of lipolytic activity. 
Results 
   1) The lipolytic activity of various organs in intact rats. Using 
the above described techinique, the LA of the lung, liver, heart, kidney 
and adipose tissue in rats (8 examples) were measured. 
   The results are shown in Table 1. The lipolytic activities of the 
heart, lung, and adipose tissue were significantly greater than those 
of the liver and kidney. 
                       Table 1. 




t Adipose Kidney' HOrgan Lungtissue
No. 1 483 283 570 534 294
2 405 238 498 453 356
3 424 256 526 434 264
4 392 300 601 505 202
5 368 344 501 537 244
6 434 273 566 474 224
7 455 242 483 521 238
8 466 307 541 514 228
Mean value 427 279 534 497
± S.±36 ±46±35 ±31
        * Lipolytic Activity is expressed as mµ moles/tissue protein 1 mg/hour . 
   2) The lipolytic activity after fat administration. 
   Eight rats were force-fed with olive oil by stomach tube, and 
were divided into two groups (4 : 4). The first group were killed after 
3 hours and the second group 5 hours after force-feeding. In both groups
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the lipolytic activity of the lung, adipose tissue and heart were markedly 
increased, (P<0.01) but that of the liver and kidney changed 
insignificantly. In comparing these two groups, changes of the LA of 
the organs were more marked in the first group. (See Table 2)
               Table 2. 
Lipolytic Activity after force-feeding of Olive Oil 
            by Stomach Tube.
Liver HeartOrgan
No.
O Lung t~issue5e Kidney
1 672 299 556 778 308
2 491 292 688 702 322
3 629 310 620 921 280
4 660 296 626 756 290
Mean value 612 299 623 790 301*
± S D. ±71 ±69 ±48 ±79 ±18
5 534 316 547 794 312
6 463 275 588 836 273
7 481 327 533, 609 301
8 575 261 510 664 329
Mean value 510 296 544 726 304*
± S. D. ±44 +28 +27 ±93 ±21
       Lipolytic Activity is expressed as mµ moles/tissue protein 1 mg/hour. 
        ~$ No. 1 ^No. 4 : 3' hours after the force-feeding. 
           No. 5 -- No. 8 : 5 hours after the force-feeding. 
   3) Effect of Heparin Administration in vitro. 
   The lipolytic activity of each organ in intact rats were measured 
by adding heparin into the reaction mixture. The results were given 
                       Table 3. 




t Adipose KidneyOrgan Lung' Hetissue
No. 1 518 307 609 513 308
2 532 443 548 561 287
3 560 283 591 541 266
4 518 256 587 569 280
Mean value) 532 276 I 584 546
S. D. ±18 ±20 ±22 ±20 ±14
# 100u. of Heparin was added into the Medium. 
 Lipolytic Activity is expressed as mµ moles/tissue protein 1 mg/hour.
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in Table 3. Increase of the lipolytic activity in the lung (P<0.01) and 
heart (P<0.05) were significant. There were no significant change in 
other tissues. 
   4) Effect of various inhibitors to the lipolytic activity in each organ. 
   Hitherto, the LA of organs were measured with these homogenate. 
It was thought that the tissue contains lipoprotein lipase and many 
other esterases and these enzyme would display lipolytic activity. 
   Twenty mg protamine sulfate, 1M of high density sodium chloride 
and 0.2 M of sodium fluoride were added to the reaction medium 
respectively. When protamine sulfate was added to the reaction medium, 
the pH of the medium dropped down to pH 6.2 6.3, so that the pH 
was readjusted immediately to pH 7.7-7.8 by addition of dilute sodium 
hydroxide. Thereafter the alteration of the lipolytic activities were 
observed, these results are summarized in Table 4. 
   The inhibitory effects on enzyme were 77.0-86.4% by protamine 
sulfate and 72.0-90.0% by sodium chloride in the heart, 59.0-78.8%
               Table 4. 
Effects of the Various Inhibitors on the Lipolytic 
           Activity in Intact Rats
None Inhibitory Added None Inhibitory Added None Inhibitory
0







No, of Protamine Sulfate (20mg) Sodium Chloride (1M) Sodium Fluoride (0.2M)
Organ IhbI
y InhibitorythbtSamples Added No
Effect in /o Effect m io Added None Effect in ,o
Lung 4 (182 466 61.0°0 (105 466 77.5,0 (259 441 39.2°0
Mean value (112 410 72.5 ( 67 410 84.0 (220 410 48.2
± S. D. (179 437 59.0 (136 437 68.6 (242 378 36.5
( 77 364 78.8 (112 364 69.0 (228 448 49.2
678+82
Liver 4 (266 344 22.8 (263 344 23.8 (109 344 68.4
Mean value (157 276 43.3 (185 276 32.1 (116 317 63.7
± S. D. (184 300 38.6 (202 300 31.8 (102 279 63.5
(228 327 30.2 (279 327 14.5 ( 96 327 70.2
33.7± 8.0 25.6± 7.2 66.5± 2.9
Heart 4 ( 68 491 86.4 ( 93 491 80.8 (315 491 36.0
Mean value ( 50 565 84.5 ( 65 565 88.2 (423 565 30.0
F S. D. (107 498 78.2 ( 50 498 90.0 (354 498 28.5
(111 484 77.0 (136 484 72.0 (330 484 31.8
7.1 31.6± 2.8
Adipose ( 56 482 88.5 ( 64 42 86.8 (353 482 26.6
tissue 4 ( 92 445 70.0 (120 445 73.0 (297 465 36.2
Mean value ( 48 497 90.4 (152 497 68.5 (321 497 35.4
± S. D. (104 421 75.2 (121 421 70.1 (288 421 30.5
+11 97.2 32.2± 3.9
Kidney 4 (115 294 60.5 (135 294 54.0 (224 294 23.4
Mean value ( 96 224(148 224(122 224 45.0
± S. D. (122 304 59.9 (152 304 49.5 (178 304 40.8
(106 238 55.5 (109 238 54.0 (125 238 47.2
583+ 21 479+ 8.1 39.1± 7.9
 LA is expressed as my moles/tissue protein 1 mg/hour,
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by protamine sulfate and 68.6-84.0% by sodium chloride in the lung, 
70.0-90.4% by protamine sulfate and 68.5-86.8% by sodium chloride 
in the adipose tissue. These organs were inhibited in high percentage. 
But the inhibitory effects of sodium fluoride were in low percentage in 
these three organs. On the contrary to these results, the inhibitory 
effects in the liver were 22.8-43.3% by protamine sulfate, 14.5-32.1 
 % by sodium chloride and 63.5-70.2% by sodium fluoride. 
   5) Alteration of the lipolytic activity after carbon tetrachloride 
poisoning. 
   At sixteen hours after carbon tetrachloride poisoning, they were 
sacrificed, and the LA of each organ was measured. These results are 
given in Table 5. The lipolytic activities in the adipose tissue, lung 
and heart were significantly increased (P<0.05-0.01), but those in 
the damaged liver and kidney did not show any remarkable change.
                 Table 5. 
Lipolytic Activity in Organs from Carbon Tetrachloride 
               Poisoned Subjects.
earLiver
±44
t Adipose KidneyOrgan Lung' Htissue
No. 1 530 304 632 574 214
2 483 269 596 820 292
3 516 280 664 615 244
4 612 252 596 607 272
5 456 315 581 680 289
6 486 290 608 582 306
7 442 353 544 746 258
8 435 308 589 705 278
Mean value 497 298 612 668 268*
S. D. ±58+27 ±78 ±27
        '~ Lipolytic Activity is expressed as m,t moles/tissue protein 1 mg/hour . 
   For the purpose to find the alteration of the LPL activity itself, 
the inhibitory effects by protamine sulfate, sodium chloride and sodium 
fluoride were measured, and these results are summarized in Table 6. 
The inhibitory effects were 63.4-71.0% by protamine sulfate and 52.5 
- 60 .3 % by sodium fluoride in the lung, 67.0 - 76.6 % by protamine 
sulfate and 49.3-53.0% sodium fluoride in the adipose tissue, 75.0-
81.4% by protamine sulfate and 27.2-42.0% by sodium fluoride in the 
heart, 40.3-55.6%, by protamine sulfate and 30.6-42.2% by sodium 
fluoride in the kidney. 
   A remarkable change was found in the inhibitory effect in adipose 
tissue by sodium fluoride (P<0.01). The increment of the lipolytic
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                        Table 6. 
         Effects of the Various Inhibitors on the Lipolytic 








No, of Protamine Sulfate (20mg) Sodium Chloried (1M) Sodium Fluoride (0.2M)
Organ
I Inhibitory Added None InhibitorySamples Added Noi
n o0Effect m Effect m
Lung 3 (173 516 66.5 (126 516 75.6 (299 516 42.0
Mean value (167 456 63.4 (190 456 58.0 (265 456 41.8
± S. D. (143 487 71.0 (163 487 66.3 (296 487 39.2
Liver 3 (182 280 35.0 (172 280 38.8 (133 280 52.5
Mean value (234 314 25.6 (185 314 41.2 (144 314 54.5
± S. D. (154 291 47.0 (161 291 44.6 (115 291 60.3
35.8±8.8 41.5±2.4 55.8±3.4
Heart 3 (175 702 75.0 (183 702 74.0 (511 702 27.2
Mean value (109 585 81.4 (136 585 77.0 (339 580 42.0
± S. D. (114 570 79.5 ( 94 570 83.5 (343 570 39.7
36.4+_6.5
Adipose 3 (266 615 76.6 (254 615 58.6 (312 615 49.3
tissue (209 680 69.0 (221 680 67.5 (322 680 53.0
Mean value (193 582 67.0 (213 582 63.4 (287 582 50.6
± S. D.51.0±1.5
Kidney 3 (146 244 40.3 (136 244 44.5 (170 244 30.6
Mean value (129 289 55.3 (146 289 50.6 (184 289 36.5
± S. D. (136 306 55.6 (129 306 57.8 (177 306 42.2
50.5±7.2 51.0+_ 5.4 36.5±4.7
           # LA is expressed as mµ moles/ tissue protein 1 mg/hour. 
activity in the adipose tissue would be owing to the lipase which is 
inhibited by sodium fluoride. 
   6) Alteration of the lipolytic activity after administration of carbon 
tetrachloride and olive oil. 
                       Table 7. 
    Lipolytic Activity after force-feeding of Carbon Tetrachloride 
            and Olive Oil Mixture by Stomach Tube.
HeartLiver
±
 Adipose KidneyOrgan Lungtissue
No. 1 562 269 740 635 255
2 594 298 792 812 272
3 615 308 736 672 238
4 555 322 710 820 245
Mean value 581 301 745 735 251
S. D, i-27 ±21 ±31 ±15 ±14
* Lipolytic Activity is expressed as mµ moles/tissue protein 1 mg/hour .
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   At sixteen hours after administration of carbon tetrachloride and 
olive oil mixture to the rats, they were sacrificed and the LA of each 
organ was measured. The results are given in Table 7. 
   The increase of the LA in the lung were somewhat higher than 
those only carbon tetrachloride was administered. There was no change 
on the LA in the liver. The increase of the LA in the adipose tissue 
was almost in same degree, and in the heart was higher than those 
only carbon tetrachloride was administered (P<0.01). 
   7) Alteration of the lipolytic activity after aseptic pneumonia. 
   Twenty-four hours after aseptic pneumonia was induced by silver 
nitrate solution administration in rats, they were sacrificed and the LA 
of each organ were determined. The results are summarized in Table 8.
               Table 8. 
Lipolytic Activity after Aseptic Pneumonia which 





No. 1 589 273 687 704 242
2 532 248 733 646 230
3 623 285 641 765 251
4 504 232 706 605 273
5 532 266 725 776 254
Mean value 556 260 699 700 251*
± D. ±42±65 ±15
i
±±19 34
* Lipolytic Activity is expressed as m -t moles/tissue protein 1 mg/hour
   In the lung tissue and also in the adipose tissue, the lipolytic 
activities were increased (P<0.01), similar to those of the carbon 
tetrachloride administration. There were no remarkable change in the 
liver and kidney. In the heart tissue, the LA was somewhat increased 
(P<O.01). 
   In this experiment, the inhibitory effects were 57.0-67.1% by 
protamine sulfate and 38.8-49.4% by sodium fluoride in the lung, 
31.8-44.0% by protamine sulfate and 45.4-64.0% sodium fluoride in 
the liver, 53.0 - 77.1 % by protamine sulfate and 42.6 - 56.4 % by sodium 
fluoride in the adipose tissue, 69.8 - 80.5 % by protamine sulfate and 
33.8 - 45.4% by sodium fluoride in the heart, 52.6 - 60.0 % by protamine 
sulfate and 34.2-42.5% by sodium fluoride in the kidney. 
   The inhibitory effects in the adipose tissue by sodium fluoride 
increasen significantly (P<0.01) similar to the carbon tetrachloride 
poisoning. (Table 9)
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                        Table 9. 
         Effects of the Various Inhibitors on the Lipolytic 
                Activity after Aseptic Pneumonia
Inhibitors






ini orory d ed oneone
No, of Protamine Sulfate (20mg) Sodium Chloride (1M) Sodium Fluoride (0.2M)
Organ -Ihb'tIhbt
y   I i it r Added N
E_ ffect in_ in ;Effect in °o
Lung 3 (217 589 63.1°0 (189 589 68.0°0 (298 5891 49.4%
Mean value (175 532 67.1 (214 532 59.9 (325 532 38.8
± S. D. (217 504 57.0 (186 504 63.0 (301 504 42.0
3.3 43.5± 4.4
Liver 3 (186 272 31.8 (201 272 26.1 (149 272 45.4
Mean value (164 248 33.8 (161 248 35.0 ( 90 248 62.6
± S. D. (130 232 44.0 (155 232 33.4 ( 84 232 64.0
36.5±5.4 31.4±3.9 52.0±10.0
Heart 3 (149 688 78.4 (122 688 82.1 (428 688 37.8
Mean value (222 734 69.8 (149 734 79.6 (485 734 33.8
± S. D. (137 707 80.5 (156 707 77.9 (386 707 45.4
39.0± 4.8
Adipose (331 704 53.0 (184 704 74.0 (307 704 56.4
tissue 3 (147 646 77.1 (240 646 68.5 (323 646 50.0
Mean value (216 605 64.0 (151 605 75.0 (348 605 42.6
D. 648+g8 725+29 49.7± 5.6
Kidney 3 ( 97 242 60.0 (115 242 52.5 (139 242 42.5
Mean value (109 230 52.6 ( 85 230 63.1 (151 230 34.2
(124 273 54.5 (121 273 44.4 (161 273 41.2
55.7±3.1 53.417.73.6
          LA is expressed as mµ moles/tissue protein 1 mg/hour. 
                   DISCUSSION 
   Since Hahn had observed the clearing phenomen of lipemic plasma 
after heparin administration, it was accepted by many investigators'" 
11)'7) that a lipolytic or lipemia clearing enzyme appears in plasma soon 
after intravenous injection of heparin, though this enzyme was not yet 
shown in pure form. 
    Thereafter E . D. KORN'", J. I . KESSLER"', M. FINKEL, D. S. ROBINSON 
30) , G. ANGERVALL, A. DURY31I and J. SLACKS'') have observed that the 
activity of lipoprotein lipase were in the heart, aorta, adipose tissue, 
pancreas and mammary gland. 
   D. S. ROBINSON and J. E. FRENCH") suggested about the relation 
between LPL in plasma and tissue that LPL occurs on the capillary 
surface and the role of heparin would be to displace and release this 
enzyme into the blood stream. Furthermore, D. S. ROBINSON and P. M. 
HARRIS34)35 suggested that the vascular component having responsibility 
for the production of LPL might be distributed generally in the walls 
of vessels.
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   In this study, it was shown that the heart and the adipose tissue 
have high lipolytic activity by means of the improved assay system, as 
in the leading investigators have reported. However, it was also shown 
that the lung has high lipolytic activity which was approximately the 
same as in heart and adipose tissue. 
   These results would be very important as a key to study the 
relationship between the lung and neutral lipid metabolism. 
   Among the lipolytic activity of each organ after administration of 
fat, the lipolytic activity in lung was increased as high as in the heart 
and the LA tend to elevate after fat ingestion, except it in liver. Most 
remarkable changes were noted in adipose tissue, lung and heart. 
   However, the addition of heparin into assay system elevated the LA 
of lung and heart, but did not change significantly in adipose tissue. 
The elevation of the LA was more marked in the lung than in the 
heart. 
   J. I. KESSLER") reported that post-Lipomul lipolytic activity was 
essentially similar to those of post-heparin plasma and H. ENGELBERG37) 
demonstrated that after infusion of Lipomul, endogeneous heparin 
increased in blood stream. 
   These facts are sufficient to assume that chylomicrons have caused 
the production or the release of heparin and the secondary production 
of LPL. 
   The results, obtained in this study, support this aspect, and also 
suggest that the lung would be the main organ to produce LPL, because 
the addition of heparin in vitro caused to elevate the LA remarkably 
mainly in lung. The liver is thought to be only a site of destruction 
and it is reasonable that the liver did not show any change. 
   HAVEL et alas' observed in the tracer experiment that 1/3 of the 
exogeneous lipid, which was as chylomicron in blood, was taken up in 
liver by means of pynocytosis and 2/3 of that in extrahepatic cells by 
means of LPL, although how LPL play a role to take up the triglyceride 
in extrahepatic cells is quite unknown. 
   Amoung the extrahepatic cells, the attitude of LPL in adipose 
tissue would have something different to those of lung and heart, 
because addition of heparin in vitro did not show any effect. 
   The lipolytic activity was not only shown by the LPL but also by 
the pancreatic lipase, because the assay system does not detect comp-
letely the LPL alone. The present results on various inhibitors demon-
strate these facts. 
   The proportion of LPL inhibited by protamine sulfate, to pancreatic 
lipase (PL) inhibited by sodium fluoride, were similar in all organ 
except liver. It was observed in the liver damaged group and the 
aseptic pneumonia group, that the lipolytic activity in adipose tissue, 
lung and heart were elevated in comparing with the intact group,
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however the proportion of LPL to PL in LA of lung and heart were 
mostly similar to that in intact group and those in LA of adipose 
tissue were changed to the increase of PL in both group compared 
with intact group. 
   Although the disturbance of lipid metabolism in aseptic pneumonia 
is quite unknown, there were many studies on the fatty liver induced 
by carbon tetrachloride poisoning. D. N. CARBERT and T. M. BRODY")4o) 
proposed an hypothesis that the characteristic hepatic change by carbon 
tetrachloride poisoning were the results of a stimulation of the sympa-
thetic nervous system, which caused the restriction of blood flow in 
liver, and finally let it to necrosis around the central vein of the 
lobule, and also which caused to increase the release of NEFA from 
the peripheral fat depot. 
    R. O . RECKNAGEL, B. LOMBARDI and M. C. SCHOTZ41 recently 
presented the hypothesis, that the liver is constantly secreting a large 
quantities of triglyceride into the blood stream and the carbon tetra-
chloride would blockade this secretory mechanism. 
   INOUE et al`' reported from the other point of view that the fatty 
acid pattern in the fatty liver, induced by carbon tetrachloride injection, 
were almost the same as that in adipose tissue. 
   From these hypothesis and results it could be supposed that the 
Tipid flows mainly from adipose tissue to liver in carbon tetrachloride 
poisoned animals. 
   From the above mentioned it would be reasonable to consider the 
LA in the adipose tissue increase to release NEFA. 
   Although why the LA in lung and heart were increased in these 
instances are unknown, it would be very favorable to understand that 
LPL play a role to take up the triglyceride and PL to release the 
NEFA. Aseptic pneumonia also demonstrated almost similar pattern in 
the inhibitory study and the LA activity to those in carbon tetrachloride 
poisoning. 
   These results showed that the dynamic state of lipid in aseptic 
pneumonia were severe as it in fatty liver. 
   Finally, it is very difficult to explain clearly the mechanism of the 
lipid metabolism disturbance in aseptic pneumonia, however these 
experiments show the important role of the lung in neutral lipid 
transportation. 
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